14:39:34 EDT Fri 09 May 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Nervgen Pharma Corp
Symbol NGEN
Shares Issued 70,936,449
Close 2025-04-14 C$ 2.94
Market Cap C$ 208,553,160
Recent Sedar Documents

Nervgen Pharma prospectus offering

2025-04-14 21:03 ET - Prospectus Approved

Financing type:  at-the-market prospectus offering

Gross proceeds:  $1,639,761 in the quarter ended March 31, 2025

Offering:  564,500 listed shares

Offering price:  an average price of $2.91 per listed share

Disclosure:  Refer to the prospectus supplement dated Dec. 19, 2024, and the company's news release dated April 9, 2025.

© 2025 Canjex Publishing Ltd. All rights reserved.